BioTrinity 2022
BioTrinity 2022: Catalysing Growth in the Life Sciences Industry
BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry.
The event is attended by an ever-evolving audience of early stage and emerging life sciences R&D Companies, investors, large pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.
Interacting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased.
BioTrinity 2022 will feature:
A dedicated 'Scientific Track', featuring a focus on seven core therapy areas; Oncology, CNS, Microbiome, Inflammation, Rare Disease, Infectious Diseases, as well as AI & Data. Each dedicated session will include an expert update from a key opinion leader, followed by up to 10 showcase presentations from some of the most innovative and interesting R&D companies.
A second 'life sciences business' focused presentation track, that will feature discussions and keynotes addressing topics from finance and investment, regulatory, government strategy and tax.
Pre-scheduled live & in-person private partnering meetings during the two-day physical conference as well as a bonus third day of virtual only partnering on Thursday 28 April 2022
A sponsors exhibition area and plenty of 'all-delegate' networking opportunities throughout both in-person day, which are so valuable to share knowledge and unlock future collaboration and new business opportunities.
Option for registered delegates to revisit recorded presentations in the days following the conference.